Skip to main content
Premium Trial:

Request an Annual Quote

Peter Meintjes

Omixon has appointed Peter Meintjes as CEO. Meintjes replaces current CEO Tim Hague who will step into a consultancy role and remains a shareholder of the company. Most recently, Meintjes served as chief commercial officer at Omixon. He joined the company in 2014.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.